Safety Follow-up Study of Participants Dosed With INV-347 in Study INV-CL-108

Locations

Canada

Start date

06/08/2025

Identifiers

Trial ID NN9441-8452,
NCT number NCT07153172,
Eudract number Not Available

Summary

The study looks at the safety and blood levels of the study drug INV-347 in participants who were previously dosed with INV-347 in study INV-CL-108. Participants will not get any study drug in this study as it looks into the safety of a drug previously dosed. The study will last for about 2 years.

Trial Overview:

Condition

Obesity

Treatment

DRUG: INV-347

Study type

INTERVENTIONAL

Trial duration

Aug 06 2025 - Sep 15 2027

Participants

Phase

Are you eligible?

Gender

Male and female

Age

18 years and older

Find out how you can participate

Questions or concerns

Do you have any question about what it’s like being a clinical volunteer? Have a look at our answers to frequently asked questions.

Find answers in our FAQs

This site contains information about clinical trials sponsored by Novo Nordisk. It is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. The information on this site should not be relied on as the basis for any decision or action. Only a physician can determine whether a specific product is correct for a particular patient. If you have questions regarding any information contained on this site you should consult a physician.